Track topics on Twitter Track topics that are important to you
HERNDON, Va., June 2, 2015 (GLOBE NEWSWIRE) -- ePlus inc. (Nasdaq:PLUS) today announced that its subsidiary, ePlus Technology, inc., has achieved the Unified Contact Center Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation recognizes ePlus as having fulfilled the training requirements and program prerequisites to sell, deploy, and support Cisco Unified Contact Center solutions targeted to the high-end enterprise contact center marketplace.
"We're pleased to add another ATP designation to our list of Cisco credentials," said Jerry McIntosh, senior vice president of advanced technology solutions for ePlus Technology. "Cisco Unified Contact Center Enterprise enables us to help customers rapidly deploy a distributed contact center infrastructure with personalized self-service to callers and leverage business intelligence necessary to create more efficient workflows in their contact center."
To qualify for Cisco Unified Contact Center ATP status, ePlus had to meet a number of requirements, from achieving the Cisco Advanced Unified Communications Specialization to maintaining high levels of customer satisfaction. Channel partners must have staff that can fulfill specific job responsibilities. Partners are also required to build a lab for development and customer-fault replication. The lab must contain current, upgraded, and maintained Cisco Unified CCE solutions, each configured for real world testing to simulate actual end-user conditions.
The Cisco Authorized Technology Provider (ATP) Program is part of Cisco's go-to-market strategy for emerging technologies. The program helps Cisco to define the knowledge, skills, and services that channel partners need to successfully sell, deploy, and support an emerging technology. As the market changes, an ATP may be discontinued or evolve into a Cisco specialization.
ePlus is a Cisco Gold Certified Partner with Cisco Master Specializations in Security, Collaboration, Cloud Builder, and Managed Services. ePlus has Cisco Powered designations in Managed Business Communications and Managed Security Services. In addition, ePlus holds Cisco Advanced Specializations in Data Center Architecture, Borderless Network Architecture, Routing and Switching, Security, Content Security, and Unified Computing. ePlus also holds Cisco Authorized Technology Provider designations in Data Virtualization, Application Centric Infrastructure, TelePresence Video Master, Physical Security (Video Surveillance and Access Control), Identity Services Engine, Enterprise Mobility Services Platform, ServiceGrid, Unified Contact Center Enterprise, Energy Management Suite Integrator, and Telehealth Reseller as well as Cisco Authorized Partner status in Service Provider Video. ePlus has consistently been recognized by Cisco for Excellence in Customer Satisfaction. For more information about Cisco solutions from ePlus, visit www.eplus.com/cisco.
About ePlus inc.
ePlus is an engineering-centric solutions provider that helps organizations imagine, implement, and achieve more from their technology. The company holds the highest certifications from top technology partners and has expertise in key transformative technologies, from data center to security, cloud, and collaboration. Founded in 1990, ePlus has more than 975 associates serving commercial, state, municipal, and education customers nationally. The Company is headquartered at 13595 Dulles Technology Drive, Herndon, VA, 20171. For more information, visit www.eplus.com, call 888-482-1122, or email firstname.lastname@example.org. Connect with ePlus on Facebook at www.facebook.com/ePlusinc and on Twitter at www.twitter.com/ePlus. ePlus. Where Technology Means More.™
ePlus®, Where Technology Means More™, and ePlus products referenced herein are either registered trademarks or trademarks of ePlus inc. in the United States and/or other countries. The names of other companies, products, and services mentioned herein may be the trademarks of their respective owners.
Cisco, the Cisco logo and Cisco Systems are registered trademarks of Cisco Systems Inc. in the United States and certain other countries.
Statements in this press release that are not historical facts may be deemed to be "forward-looking statements." Actual and anticipated future results may vary materially due to certain risks and uncertainties, including, without limitation, possible adverse effects resulting from financial market disruption and general slowdown of the U.S. economy such as our current and potential customers delaying or reducing technology purchases, increasing credit risk associated with our customers and vendors, reduction of vendor incentive programs, and restrictions on our access to capital necessary to fund our operations; our ability to consummate and integrate acquisitions; the possibility of goodwill impairment charges in the future; significant adverse changes in, reductions in, or losses of relationships with major customers or vendors; the demand for and acceptance of, our products and services; our ability to adapt our services to meet changes in market developments; our ability to implement comprehensive plans for the integration of sales forces, cost containment, asset rationalization, systems integration and other key strategies; our ability to reserve adequately for credit losses; our ability to secure our electronic and other confidential information; future growth rates in our core businesses; our ability to protect our intellectual property; the impact of competition in our markets; the possibility of defects in our products or catalog content data; our ability to adapt to changes in the IT industry and/or rapid change in product standards; our ability to realize our investment in leased equipment; our ability to hire and retain sufficient qualified personnel; and other risks or uncertainties detailed in our reports filed with the Securities and Exchange Commission. All information set forth in this press release is current as of the date of this release and ePlus undertakes no duty or obligation to update this information.
CONTACT: Kleyton Parkhurst, SVP ePlus inc. email@example.com 703-984-8150NEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...